% Expired Patents = 75.0

Forward Citations = 0

Loading Chart...

3 inventors (with patents filed for the assignee):

Hooshmand Sheshbaradaran (2 out of 6 patents)

Rickey Roy Rhinebarger (2 out of 2 patents)

Gina G Stetsko (2 out of 2 patents)

4 patents: Sort by Forward Citations

1. 11135212 - Method for treating osteoporosis, osteopenia or low bone mineral density (2021-10-05),

2. 10933021 - Compositions of gallium (III) complexes for oral administration (2021-03-02),

3. 10548849 - Compositions of gallium (III) complexes for oral administration (2020-02-04),

4. 10463657 - Method for treating osteoporosis, osteopenia or low bone mineral density (2019-11-05),

Company Overview

Altum Pharmaceuticals Inc. is a leading biopharmaceutical company dedicated to developing innovative therapies for a variety of diseases. With a focus on rare and genetic disorders, our research and development team is committed to advancing scientific knowledge and improving patient outcomes. Our mission is to bring life-changing treatments to those in need, transforming the landscape of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#221 in Vancouver

#3,466 in Canada

Vancouver, Canada

Altum Pharmaceuticals Inc.

Forward Citations = 0

3 inventors:

Hooshmand Sheshbaradaran (2 out of 6 patents)

Rickey Roy Rhinebarger (2 out of 2 patents)

Gina G Stetsko (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Altum Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/altum-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]